COVID-19
Master of Bioethics (MBE)
Master of Health Care Innovation
Undergraduate Bioethics Minor
Master of Science in Medical Ethics (MSME)
Professional Development Courses/Certificate
ELSI Postdoctoral Training Fellowship
Continuing Education
News & Research
April 18, 2021 | The Associated Press

Black Americans experiencing collective trauma, grief

Many Black Americans are facing a collective sense of grief and trauma that has grown more profound with the loss of each life at the hands of police in America.

Read More
April 14, 2021 | Newsweek

Biden's Infrastructure Plan Recognizes Our Invisible Home Care Workers

When President Biden included $400 billion for home health care in his $2 trillion infrastructure plan, he acknowledged what home care workers have known for decades: They are the infrastructure that keeps the industry intact, and they are an infrastructure that is crumbling and badly in need of repair.

Read More
April 14, 2021 | The Philadelphia Inquirer

Dementia, Alzheimer’s have reached crisis point, Penn researcher says. Here’s what we can do about it.

Mild cognitive impairment, dementia, and Alzheimer’s now affect so many people — those with symptoms, plus their caretakers — that Jason Karlawish, of the Penn Memory Center, terms it a crisis.

Read More
See All News
Events
April
20
via Zoom

Penn Bioethics Seminar Series (PBS): Naomi Scheinerman, PhD

Learn More 2021-04-20 12:00:00 2021-04-20 13:00:00 America/New_York Penn Bioethics Seminar Series (PBS): Naomi Scheinerman, PhD Meaningful Engagement in Regulating Biotechnologies  through Mini-Public Deliberation   Naomi Scheinerman, PhD, Fellow in Ethical, Legal, and Social Implications of Genetics and Genomics, Medical Ethics and Health Policy, PSOM Registration required for all events.  Meeting link will be provided automatically upon sign-up. Sign up here: https://zoom.us/meeting/register/tJUuc-ugpzkvEtHm8L_7nw9tHhrpXySGvTKd Designed to manage risks and ensure the safety of industry’s innovations, regulatory agencies have long been objects of interest for bioethicists due to the significant power and influence they have over new and emerging biotechnologies’ impact on people’s lives. However, agencies’ ability to regulate effectively suffer from lack of adequate pathways for inclusivity due to expert-based design, captured interests, and barriers to entry during the comment process. I argue that this notorious “democratic deficit” can be reduced by importing a recent institutional innovation called “mini-publics” (bodies of randomly selected individuals) within the regulatory process earlier in rulemaking in order to add needed diversity of views and lived experiences. In particular, in accordance with the Coordinated Framework for the Regulation of Biotechnology’s purported interest in engaging the public, this procedural innovation can help the agencies under its purview, such as the FDA, USDA, and EPA achieve their missions of creating considered judgment of risks and values of gene editing applications. Please email mary.pham@pennmedicine.upenn.edu to be added to the listserv to receive passwords and announcements. via Zoom Penn Medical Ethics
April
27
via Zoom (REGISTRATION REQUIRED)

Penn Bioethics Seminar Series (PBS): Aliza Narva, JD, MSN

Learn More 2021-04-27 12:00:00 2021-04-27 13:00:00 America/New_York Penn Bioethics Seminar Series (PBS): Aliza Narva, JD, MSN Clinical case: TBA    Aliza Narva, JD, MSN, Director of Ethics at the Hospital of the University of Pennsylvania Open only to those affiliated with PSOM, HUP, or CHOP.  Registration required: https://zoom.us/meeting/register/tJcvc-uoqT8oHtXwAPiox_sztt5yUEc3Qp7K  Please email mary.pham@pennmedicine.upenn.edu to be added to the listserv to receive passwords and announcements. via Zoom (REGISTRATION REQUIRED) Penn Medical Ethics
May
3
via Zoom

Research Ethics and Policy Series (REPS) | Genevieve Kanter, PhD

Learn More 2021-05-03 12:00:00 2021-05-03 13:00:00 America/New_York Research Ethics and Policy Series (REPS) | Genevieve Kanter, PhD The Revolving Door in Health Policy and the FDA   Genevieve Kanter, PhD Assistant Professor of Medicine and Medical Ethics, Perelman School of Medicine Register in advance via Zoom: https://zoom.us/j/94075904209  As the Biden administration begins to select its nominees for political appointments, there has been renewed concern about the corrupting effects of the "revolving door." In the context of regulation, the revolving door is defined as the movement of employees between regulatory agencies and the industries they regulate and is thought to render regulatory decisions more vulnerable to industry interests. I review federal revolving door regulations and recent empirical studies on the effects of the revolving door and present a preliminary analysis of the problem of the revolving door in health policy, the FDA, and research standards for drug approval. Please contact Mary Pham (mary.pham@pennmedicine.upenn.edu) if you would like to be added to the Medical Ethics events listserv. via Zoom Penn Medical Ethics
May
4
via Zoom

Penn Bioethics Seminar Series (PBS): Isabel Gabel, PhD

Learn More 2021-05-04 12:00:00 2021-05-04 13:00:00 America/New_York Penn Bioethics Seminar Series (PBS): Isabel Gabel, PhD TBA   Isabel Gabel, PhD, Fellow in Ethical, Legal, and Social Implications of Genetics and Genomics, Medical Ethics and Health Policy, PSOM  Registration required for all events.  Meeting link will be provided automatically upon sign-up. Sign up here: https://zoom.us/meeting/register/tJAscu2pqzgoGNB_s1gqYmPKqqiMmU-Z9xL5 Please email mary.pham@pennmedicine.upenn.edu to be added to the listserv to receive passwords and announcements. via Zoom Penn Medical Ethics
See All Events

Loading tweets...